Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ronran,
We already know the numbers of the OS from the Proxy Statement: "The number of shares of Common Stock outstanding as of February 28, 2007, was 378,668,118. " And then you take a further look to the principal shareholders list and you'll see the amount of warrants as of Feb 28th: "Includes 23,845,100 shares issuable upon the exercise of warrants." (Only warrants from Lincoln). Plus 6,850,000 shares for the BOD issuable upon exercise of outstanding stock options exercisable within 60 days of February 28, 2007.
Share
New Message
Please login to post a reply